PBC News
-
Mindset Medical Announces FDA Clearance for its Contactless Respiratory
Phoenix, Arizona – June 3, 2025 – Mindset Medical, Inc. (“Mindset Medical” or the “Company”), a digital health company, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its latest contactless vital sign monitoring solution. The Informed Vital Core (IVC) App is a software-only medical device that measures respiratory rate…
-
Technology Developed by ANBM to be Utilized for New Drug Discovery Program
Dr. Zenhausern (second from right) attended the press conference in Japan to announce the groundbreaking partnership. Collaboration with Mitsubishi Gas Chemical Company, Inc. will see the tech adopted in the research of Ehime University Furthering the University of Arizona College of Medicine – Phoenix’s research mission to cultivate research both locally and globally, the Center for…
-
Strongest Connection Found to Dementia in the South
A “substantial number” of dementia cases in the United States could be eliminated by reducing cardiometabolic conditions such as heart attack, stroke, and diabetes, according to a new study from Barrow Neurological Institute in Phoenix. The study, which was recently published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, probed regional data and found the strongest tie between dementia…
-
ASU to help target how cancer evades treatment
Up to $142M in funding announced for research group that includes MIT and Stanford Every year, about 2 million Americans are diagnosed with cancer, and more than 600,000 of them have cancer that spreads or no longer responds to treatment because of cancer cell mutations. Researchers at Arizona State University aim to solve this by…
-
ASU partners with biotech luminary to launch life science business program
Gift funds McKenna Life Sciences, Business and Entrepreneurship Program designed for health care leaders Mark and Sheri McKenna. Courtesy photo From driving research breakthroughs to bringing new treatments to market, life sciences and business professionals are increasingly in demand. Arizona State University is meeting that demand with the launch of the McKenna Life Sciences, Business and…
-
Study says original COVID-19 vaccination did not stop immune system from fighting variants
Vaccinated people generated an overall protective immune response to the Delta and Omicron strains of COVID-19, though with slightly fewer antibodies for the mutated parts of the virus. Prior COVID-19 vaccination did not stop the immune system from mounting a protective response to the Delta and Omicron strains, though new mutation-specific antibody production dipped slightly,…
-
Blue Cross Blue Shield of Arizona Supports the College of Nursing
More students across northern Arizona will soon have new opportunities to pursue nursing careers, thanks to a $100,000 donation from Arizona’s Blue Cross Blue Shield to NAU’s College of Nursing. The funding supports the launch of NAU’s new Global Bachelor of Science in Nursing (Global BSN) program, designed to expand access to nursing education for students…
-
Mayor Gallego Delivers 2025 State of the City Address
Mayor Kate Gallego today delivered her annual State of the City address, sharing that amid the “chaos and confusion coming from our government in Washington,” Phoenix and its City Council are “leading with competence and collaboration.” Gallego said the approach is working. “We’ve created more jobs, and good jobs—the kind that change lives,” she said. …
-
HonorHealth Research Institute patient with advanced skin cancer in remission for more than a year following clinical trial of WTX-124
There are nearly 40,000 U.S. cases of cutaneous squamous cell carcinoma each year that advance to stages that are difficult to treat and life-threatening SCOTTSDALE, Ariz. — May 20, 2025 — A common and unsightly skin cancer that can turn deadly has been undetectable for more than a year in a patient treated with a new…
-
Developing the personalized future of cancer treatment
A CAMI scientist is leading efforts to create a new kind of cancer immunotherapy – neoantigen-specific cancer vaccines – to target patient-specific tumors and destroy cancer cells. Tanvir Ahmed, PhD, has dedicated his career to advancing vaccine development and immunotherapy. Now, as a principal scientist at the University of Arizona Health Sciences Center for Advanced Molecular and…
Got any book recommendations?